Yidi Zhu - Publications

Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: May 24, 2026

Anatomical Variations of Portal Vein Branches in Subsegment IVb: A 3D Reconstruction-Based Classification to Inform Radical Resection for Gallbladder Cancer.

Journal: The Journal of surgical research

Published: December 17, 2025

Efficacy and Safety of First-Line Chemotherapy With Gemcitabine Plus Nab-Paclitaxel in Unresectable Gallbladder Cancer.

Journal: Cancer medicine

Published: August 20, 2025

Extracellular Vesicle-Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion.

Journal: Cancer research

Published: May 27, 2025

Extracellular Vesicle-Mediated O-GlcNAcase Transfer Drives Neuronal Necroptosis to Facilitate Gallbladder Cancer Perineural Invasion.

Journal: Cancer research

Published: May 27, 2025

An end-to-end interpretable machine-learning-based framework for early-stage diagnosis of gallbladder cancer using multi-modality medical data.

Journal: BMC cancer

Published: December 24, 2024

TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.

Journal: Cancer letters

Published: March 10, 2024

DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis.

Journal: Cellular signalling

Published: March 28, 2023

Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy.

Journal: Frontiers in oncology

Published: June 25, 2022

LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.

Journal: Cancer letters

Published: June 21, 2022

Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study.

Journal: BMC cancer

Published: December 11, 2020

Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N-cadherin and IL-1β-dependent liver arrest and tumor extravasation.

Journal: Clinical and translational medicine

Published: May 31, 2020